Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. (PACB) Revenue
Annual & quarterly revenue history · segment & region breakdown
PACB · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsPacific Biosciences of California, Inc. trailing twelve-month (TTM) revenue is $0.16B, an increase of 3.89% year-over-year from $0.16B in FY2025.
Revenue trend
2025 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.16B | +$0.01B | +3.89% |
| 2024-12-31 | $0.15B | -$0.05B | -23.19% |
| 2023-12-31 | $0.20B | +$0.07B | +56.29% |
| 2022-12-31 | $0.13B | -$0.00B | -1.69% |
| 2021-12-31 | $0.13B | +$0.05B | +65.43% |
| 2020-12-31 | $0.08B | -$0.01B | -13.20% |
| 2019-12-31 | $0.09B | +$0.01B | +15.60% |
| 2018-12-31 | $0.08B | -$0.01B | -15.88% |
| 2017-12-31 | $0.09B | +$0.00B | +3.04% |
| 2016-12-31 | $0.09B | -$0.00B | -2.23% |
Compare revenue vs peers
Medical - DevicesCompare PACB revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Pacific Biosciences of California, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Pacific Biosciences of California, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Pacific Biosciences of California, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PACB revenue · 4 questionsPACB's trailing twelve-month (TTM) revenue is $0.16B. That is an increase of 3.89% year-over-year from $0.16B in FY2025.
▸ Source: FMP · Pacific Biosciences of California, Inc. SEC filings · GAAP · Pacific Biosciences of California, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026